The efficacy and safety of Remibrutinib in patients with Chronic Spontaneous Urticaria: A systematic review and meta-analysis of randomized controlled trials

Recent clinical trials are exploring new therapies for chronic spontaneous urticaria (CSU). We perform a meta-analysis to review the efficacy and safety of remibrutinib for the treatment of CSU.近期多项临床试验正在探索针对慢性自发性荨麻疹（chronic spontaneous urticaria，CSU）的新型治疗方案。本研究开展一项荟萃分析，以评估瑞布替尼（remibrutinib）用于治疗慢性自发性荨麻疹的疗效与安全性。